These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6996660)

  • 1. The effect of a selective beta adrenergic blocking agent on ventricular arrhythmias in the first year following myocardial infarction.
    Federman J; Whitford JA; Anderson ST; Pitt A
    Aust N Z J Med; 1980 Jun; 10(3):289-94. PubMed ID: 6996660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practolol in acute myocardial infarction.
    Barber JM; Boyle DM; Chaturvedi NC; Singh N; Walsh MJ
    Acta Med Scand Suppl; 1976; 587():213-9. PubMed ID: 130058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of practolol on the dysrhythmias complicating acute ischemic heart disease.
    Allen JD; Pantridge JF; Shanks RG
    Am J Med; 1975 Feb; 58(2):199-208. PubMed ID: 1115067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol. A multicentre international study.
    Br Med J; 1975 Sep; 3(5986):735-40. PubMed ID: 240481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous variability of ventricular arrhythmias in patients at increased risk for sudden death after acute myocardial infarction: consecutive ambulatory electrocardiographic recordings of 88 patients.
    Pratt CM; Théroux P; Slymen D; Riordan-Bennett A; Morisette D; Galloway A; Seals AA; Hallstrom A
    Am J Cardiol; 1987 Feb; 59(4):278-83. PubMed ID: 2880497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous and oral practolol in the acute stages of myocardial infarction.
    Evemy KL; Pentecost BL
    Eur J Cardiol; 1978 Jul; 7(5-6):391-8. PubMed ID: 699938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results.
    Maggioni AP; Zuanetti G; Franzosi MG; Rovelli F; Santoro E; Staszewsky L; Tavazzi L; Tognoni G
    Circulation; 1993 Feb; 87(2):312-22. PubMed ID: 8093865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects on the contractile state of the myocardium and anti-arrhythmic properties of practolol, a beta-blocking agent with cardioselective activity].
    Di Luzio V; Purcaro A; Curzi G; Di Segni E; Chiesa R; Di Giuseppe F
    Boll Soc Ital Cardiol; 1972; 17(3):179-87. PubMed ID: 4671753
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 12. Beta-adrenoceptor blockade in myocardial infarction: the continuing controversy.
    Frishman WH
    Am Heart J; 1980 Apr; 99(4):528-36. PubMed ID: 6102436
    [No Abstract]   [Full Text] [Related]  

  • 10. Incidence of ventricular arrhythmias in first year after myocardial infarction.
    Federman J; Whitford JA; Anderson ST; Pitt A
    Br Heart J; 1978 Nov; 40(11):1243-50. PubMed ID: 718763
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of beta-blockers on arrhythmias during six weeks after suspected myocardial infarction.
    Roland JM; Wilcox RG; Banks DC; Edwards B; Fentem PH; Hampton JR
    Br Med J; 1979 Sep; 2(6189):518-21. PubMed ID: 387170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in mortality after myocardial infarction with long-term beta-adrenoceptor blockade. Multicentre international study: supplementary report.
    Br Med J; 1977 Aug; 2(6084):419-21. PubMed ID: 329943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of combined treatment with lignocaine, procainamide and practolol in acute myocardial infarction.
    Nordlander R; Nyquist O
    Cardiology; 1980; 66(1):27-42. PubMed ID: 7388852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of arrhythmias during the first 24 hours of acute myocardial infarction treated with alteplase and effect of early administration of a beta-blocker or a bradycardiac agent on their incidence.
    Heidbüchel H; Tack J; Vanneste L; Ballet A; Ector H; Van de Werf F
    Circulation; 1994 Mar; 89(3):1051-9. PubMed ID: 8124790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular arrhythmias in patients recovering from myocardial infarction: do residual myocardial ischemia and anti-ischemic medical intervention influence the one-month prevalence? The Danish Study Group on Verapamil in Myocardial Infarction.
    Jespersen CM; Vaage-Nilsen M
    Clin Cardiol; 1993 Feb; 16(2):109-14. PubMed ID: 8435923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-Blocker Heart Attack Trial: impact of propranolol therapy on ventricular arrhythmias.
    Morganroth J; Lichstein E; Byington R
    Prev Med; 1985 May; 14(3):346-57. PubMed ID: 3903736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of arrhythmias with practolol (Eraldin)].
    Bach-Mortensen N
    Ugeskr Laeger; 1973 Sep; 135(37):1988-92. PubMed ID: 4129852
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined use of glucagon and beta-adrenoceptor antagonists in ventricular arrhythmias accompanying myocardial infarction.
    Madan BR; Jain BK
    Indian J Med Res; 1973 Oct; 61(10):1535-43. PubMed ID: 4781011
    [No Abstract]   [Full Text] [Related]  

  • 19. Mexiletine in the prophylaxis of ventricular arrhythmias during acute myocardial infarction.
    Campbell RW; Achuff SC; Pottage A; Murray A; Prescott LF; Julian DG
    J Cardiovasc Pharmacol; 1979; 1(1):43-52. PubMed ID: 94381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cardioselective beta-blockade on heart function and chest pain in acute myocardial infarction.
    Waagstein F; Hjalmarson AC
    Acta Med Scand Suppl; 1976; 587():193-200. PubMed ID: 1062128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.